November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...
This educational activity is intended for pulmonary specialists and other members of the health care team who care for patients with obstructive lung diseases such as COPD and asthma. Asthma and COPD ...
Humans can’t survive without taking a breath. And the lungs are the pneumatic engines that take in oxygen to be distributed ...
Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
AECOPD is associated with a significant worsening of respiratory symptoms that requires additional therapy. Several studies have indicated that AECOPD increases mortality, morbidity, and overall ...
Nuance Pharma ("Nuance") today announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA) for Ohtuvayre® ...
In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...
USA: New research has revealed that daily inhaled cannabis use was associated with a significantly increased risk of asthma ...
Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.
Lung disease is a silent and often deadly threat that lurks in the lives of smokers. For many, smoking is a habit formed over years, becoming a part of their daily routine. However, the consequences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results